SeaSpine will Participate in the Wells Fargo Securities Healthcare Conference

Rhea-AI Summary

SeaSpine Holdings Corporation (NASDAQ: SPNE), a medical technology company specializing in spinal disorder solutions, will present at the Wells Fargo Securities Healthcare Conference on September 10, 2020, at 2:00 pm ET. The event will be accessible via a live and archived webcast on the company's Investor Relations page. SeaSpine is known for its innovative orthobiologics and spinal implants that assist surgeons in spinal fusion procedures. The company operates in the United States and approximately 30 global markets, ensuring a diverse portfolio for healthcare professionals.

Positive

• Participation in the Wells Fargo Securities Healthcare Conference may enhance visibility and investor interest for SeaSpine.
• SeaSpine offers a diversified portfolio of spinal disorder treatments in over 30 countries, potentially expanding market reach.

Negative

• None.

CARLSBAD, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Wells Fargo Securities Healthcare Conference on Thursday, September 10, 2020, beginning at 2:00 pm ET.

A live and archived webcast of the event will be available from the Investor Relations page of the Company's website at investor.seaspine.com.

About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.  SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic, and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their patients' fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.

Investor Relations Contact
Leigh Salvo
(415) 937-5402
ir@seaspine.com

FAQ

What is SeaSpine's presentation date at the Wells Fargo Securities Healthcare Conference?

SeaSpine will present on September 10, 2020.

What time will SeaSpine's presentation start?

The presentation will begin at 2:00 pm ET.

Where can I watch SeaSpine's conference presentation?

The presentation will be available via a live and archived webcast on SeaSpine's Investor Relations page.

What products does SeaSpine offer?

SeaSpine offers orthobiologics and spinal implants for treating spinal disorders.

In how many countries does SeaSpine operate?

SeaSpine markets its products in approximately 30 countries worldwide.